Form 8-K - Current report:
SEC Accession No. 0001477932-25-000006
Filing Date
2025-01-02
Accepted
2025-01-02 10:30:32
Documents
15
Period of Report
2024-12-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 24784
  Complete submission text file 0001477932-25-000006.txt   151974

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bglc-20241227.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20241227_lab.xml EX-101.LAB 15195
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20241227_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20241227_pre.xml EX-101.PRE 9631
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20241227_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4042
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 25500685
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)